| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
22,769 | 17,141 | 16,640 | 13,711 | 10,451 | 7,220 | 5,129 | 4,369 | 4,344 |
General and administrative | ||||||||
39,857 | 5,924 | 5,500 | 4,743 | 3,614 | 2,259 | 1,000 | 803 | 516 |
Total operating expenses | ||||||||
62,626 | 23,065 | 22,140 | 18,454 | 14,065 | 9,479 | 6,129 | 5,172 | 4,860 |
Loss from operations | ||||||||
-62,626 | -23,065 | -22,140 | -18,454 | -14,065 | -9,479 | -6,129 | -5,172 | -4,860 |
Other income, net | ||||||||
1,908 | 2,106 | 1,657 | 1,312 | 518 | 461 | 132 | 135 | 127 |
Net loss | ||||||||
-60,718 | -20,959 | -20,483 | -17,142 | -13,547 | - | -5,997 | -5,037 | - |
Other comprehensive income: | ||||||||
Unrealized loss on marketable securities | ||||||||
-316 | - | -24 | 345 | - | - | - | - | - |
Comprehensive loss | ||||||||
-61,034 | -21,009 | -20,507 | -16,797 | -13,547 | -9,018 | -5,997 | -5,037 | -4,733 |
Net loss per share, basic and diluted | ||||||||
-1.69 | 2.31 | -0.63 | -0.70 | -3.97 | -2.64 | -1.77 | -1.49 | -1.41 |
Weighted-average common shares outstanding, basic and diluted | ||||||||
35,919 | 36,293 | 32,312 | 24,479 | 3,413 | 3,410 | 3,394 | 3,380 | 3,368 |